# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001213900-19-017510
Filing Date
2019-09-09
Accepted
2019-09-09 16:31:43
Documents
40
Period of Report
2019-09-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CURRENT REPORT | f8k090919inmunebio.htm | 8-K | 18058
2 | PRESENTATION | f8k0919ex99-1_inmunebio.htm | EX-99.1 | 35822
3 | GRAPHIC | ex99-1_001.jpg | GRAPHIC | 238391
4 | GRAPHIC | ex99-1_002.jpg | GRAPHIC | 369287
5 | GRAPHIC | ex99-1_003.jpg | GRAPHIC | 283369
6 | GRAPHIC | ex99-1_004.jpg | GRAPHIC | 215675
7 | GRAPHIC | ex99-1_005.jpg | GRAPHIC | 163606
8 | GRAPHIC | ex99-1_006.jpg | GRAPHIC | 300288
9 | GRAPHIC | ex99-1_007.jpg | GRAPHIC | 269927
10 | GRAPHIC | ex99-1_008.jpg | GRAPHIC | 168943
11 | GRAPHIC | ex99-1_009.jpg | GRAPHIC | 159331
12 | GRAPHIC | ex99-1_010.jpg | GRAPHIC | 197761
13 | GRAPHIC | ex99-1_011.jpg | GRAPHIC | 168625
14 | GRAPHIC | ex99-1_012.jpg | GRAPHIC | 142190
15 | GRAPHIC | ex99-1_013.jpg | GRAPHIC | 232501
16 | GRAPHIC | ex99-1_014.jpg | GRAPHIC | 205057
17 | GRAPHIC | ex99-1_015.jpg | GRAPHIC | 159242
18 | GRAPHIC | ex99-1_016.jpg | GRAPHIC | 151010
19 | GRAPHIC | ex99-1_017.jpg | GRAPHIC | 215795
20 | GRAPHIC | ex99-1_018.jpg | GRAPHIC | 208189
21 | GRAPHIC | ex99-1_019.jpg | GRAPHIC | 128676
22 | GRAPHIC | ex99-1_020.jpg | GRAPHIC | 200838
23 | GRAPHIC | ex99-1_021.jpg | GRAPHIC | 167501
24 | GRAPHIC | ex99-1_022.jpg | GRAPHIC | 221133
25 | GRAPHIC | ex99-1_023.jpg | GRAPHIC | 146201
26 | GRAPHIC | ex99-1_024.jpg | GRAPHIC | 168682
27 | GRAPHIC | ex99-1_025.jpg | GRAPHIC | 218669
28 | GRAPHIC | ex99-1_026.jpg | GRAPHIC | 239816
29 | GRAPHIC | ex99-1_027.jpg | GRAPHIC | 162542
30 | GRAPHIC | ex99-1_028.jpg | GRAPHIC | 287187
31 | GRAPHIC | ex99-1_029.jpg | GRAPHIC | 167136
32 | GRAPHIC | ex99-1_030.jpg | GRAPHIC | 182594
33 | GRAPHIC | ex99-1_031.jpg | GRAPHIC | 193995
34 | GRAPHIC | ex99-1_032.jpg | GRAPHIC | 203436
35 | GRAPHIC | ex99-1_033.jpg | GRAPHIC | 180354
36 | GRAPHIC | ex99-1_034.jpg | GRAPHIC | 176617
37 | GRAPHIC | ex99-1_035.jpg | GRAPHIC | 170839
38 | GRAPHIC | ex99-1_036.jpg | GRAPHIC | 149117
39 | GRAPHIC | ex99-1_037.jpg | GRAPHIC | 231827
40 | GRAPHIC | ex99-1_038.jpg | GRAPHIC | 148860
| Complete submission text file | 0001213900-19-017510.txt |  | 9881026

Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 191083375
SIC: 2836 Biological Products, (No Diagnostic Substances)